129 related articles for article (PubMed ID: 15914951)
21. Cardiac MR spectroscopy in the new millennium.
Pohost GM; Meduri A; Razmi RM; Rathi VK; Doyle M
Rays; 2001; 26(1):93-107. PubMed ID: 11471351
[TBL] [Abstract][Full Text] [Related]
22. The relationship between plasma BNP level and the myocardial phosphocreatine/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy.
Chida K; Otani H; Kohzuki M; Saito H; Kagaya Y; Takai Y; Takahashi S; Yamada S; Zuguchi M
Cardiology; 2006; 106(3):132-6. PubMed ID: 16636542
[TBL] [Abstract][Full Text] [Related]
23. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
[TBL] [Abstract][Full Text] [Related]
24. In vivo mouse myocardial (31)P MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations.
Bakermans AJ; Abdurrachim D; van Nierop BJ; Koeman A; van der Kroon I; Baartscheer A; Schumacher CA; Strijkers GJ; Houten SM; Zuurbier CJ; Nicolay K; Prompers JJ
NMR Biomed; 2015 Oct; 28(10):1218-27. PubMed ID: 26269430
[TBL] [Abstract][Full Text] [Related]
25. Alterations in creatine metabolism observed in experimental autoimmune myocarditis using ex vivo proton magic angle spinning MRS.
Muench F; Retel J; Jeuthe S; O h-Ici D; van Rossum B; Wassilew K; Schmerler P; Kuehne T; Berger F; Oschkinat H; Messroghli DR
NMR Biomed; 2015 Dec; 28(12):1625-33. PubMed ID: 26768489
[TBL] [Abstract][Full Text] [Related]
26. MR spectroscopy of the heart.
Sardanelli F; Quarenghi M
Radiol Med; 2006 Dec; 111(8):1025-34. PubMed ID: 17171530
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopy.
Petritsch B; Köstler H; Machann W; Horn M; Weng AM; Goltz JP; Hahn D; Niemann M; Weidemann F; Wanner C; Beer M
Rofo; 2012 Nov; 184(11):1020-5. PubMed ID: 22893488
[TBL] [Abstract][Full Text] [Related]
28. Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy.
Sai E; Shimada K; Yokoyama T; Hiki M; Sato S; Hamasaki N; Maruyama M; Morimoto R; Miyazaki T; Fujimoto S; Tamura Y; Aoki S; Watada H; Kawamori R; Daida H
Heart Vessels; 2017 Feb; 32(2):166-174. PubMed ID: 27142065
[TBL] [Abstract][Full Text] [Related]
29. High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies--the study using ECG gated MR spectroscopy with a localization technique.
Masuda Y; Tateno Y; Ikehira H; Hashimoto T; Shishido F; Sekiya M; Imazeki Y; Imai H; Watanabe S; Inagaki Y
Jpn Circ J; 1992 Jun; 56(6):620-6. PubMed ID: 1625368
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease.
Leme AM; Salemi VM; Parga JR; Ianni BM; Mady C; Weiss RG; Kalil-Filho R
Arq Bras Cardiol; 2010 Aug; 95(2):264-70. PubMed ID: 20676586
[TBL] [Abstract][Full Text] [Related]
31. An investigation into potential gender-specific differences in myocardial triglyceride content assessed by 1H-Magnetic Resonance Spectroscopy at 3Tesla.
Petritsch B; Köstler H; Gassenmaier T; Kunz AS; Bley TA; Horn M
J Int Med Res; 2016 Jun; 44(3):585-91. PubMed ID: 27091860
[TBL] [Abstract][Full Text] [Related]
32. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
Hardy CJ; Weiss RG; Bottomley PA; Gerstenblith G
Am Heart J; 1991 Sep; 122(3 Pt 1):795-801. PubMed ID: 1877457
[TBL] [Abstract][Full Text] [Related]
33. [31P magnetic-resonance spectroscopy in cardiac diseases].
Mazaev VV; Stukalova OV; Ternovoĭ SK; Chazova IE
Kardiologiia; 2012; 52(3):67-73. PubMed ID: 22839445
[TBL] [Abstract][Full Text] [Related]
34. Effect of creatine monohydrate on cardiac function in a rat model of endotoxemia.
Vona-Davis L; Wearden PD; Karne NH; Hill RC
J Surg Res; 2002 Mar; 103(1):1-7. PubMed ID: 11855910
[TBL] [Abstract][Full Text] [Related]
35. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy.
Pluim BM; Lamb HJ; Kayser HW; Leujes F; Beyerbacht HP; Zwinderman AH; van der Laarse A; Vliegen HW; de Roos A; van der Wall EE
Circulation; 1998 Feb; 97(7):666-72. PubMed ID: 9495302
[TBL] [Abstract][Full Text] [Related]
36. Cardiac magnetic resonance spectroscopy: potential clinical applications.
Neubauer S
Herz; 2000 Jun; 25(4):452-60. PubMed ID: 10948781
[TBL] [Abstract][Full Text] [Related]
37. Determination of free creatine and phosphocreatine concentrations in the isolated perfused rat heart by 1H- and 31P-NMR.
Unitt JF; Schrader J; Brunotte F; Radda GK; Seymour AM
Biochim Biophys Acta; 1992 Jan; 1133(2):115-20. PubMed ID: 1731953
[TBL] [Abstract][Full Text] [Related]
38. In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease.
Schaefer S; Gober JR; Schwartz GG; Twieg DB; Weiner MW; Massie B
Am J Cardiol; 1990 May; 65(16):1154-61. PubMed ID: 2139540
[TBL] [Abstract][Full Text] [Related]
39.
Secchi F; Di Leo G; Petrini M; Spairani R; Alì M; Guazzi M; Sardanelli F
Radiol Med; 2017 Apr; 122(4):265-272. PubMed ID: 28070839
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance spectroscopy in myocardial disease.
Beadle R; Frenneaux M
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):269-77. PubMed ID: 20136613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
